Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cellular Pathology”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06010875
What this trial is testing

A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Who this might be right for
Renal Cell CarcinomaOvarian CancerCervix Cancer+2 more
Chongqing Precision Biotech Co., Ltd 48
Not applicableStudy completedNCT04602819
What this trial is testing

Photoaging Reversing After Picosecond Laser With DLA Assessed by Cellular Resolution OCT in Asian Patient With Melasma

Who this might be right for
Melasma
China Medical University Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00434330
What this trial is testing

Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis

Who this might be right for
AnemiaChronic Kidney DiseaseChronic Renal Failure
Affymax 91
Testing effectiveness (Phase 2)Study completedNCT02292628
What this trial is testing

Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence

Who this might be right for
Faecal Incontinence
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud 16
Early research (Phase 1)Study completedNCT03027128
What this trial is testing

QUILT-3.028: Study of haNK™ for Infusion in Subjects With Metastatic or Locally Advanced Solid Tumors

Who this might be right for
Solid Tumor
ImmunityBio, Inc. 6
Large-scale testing (Phase 3)WithdrawnNCT07492875
What this trial is testing

Study of Nogapendekin Alfa Inbakicept and iNKT Cells in Critically Ill Adults With Severe Community-Acquired Pneumonia

Who this might be right for
Community-Acquired Pneumonia (CAP)Acute Respiratory Distress Syndrome (ARDS)Sepsis+2 more
ImmunityBio, Inc.
Early research (Phase 1)Looking for participantsNCT05948865
What this trial is testing

CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
CancerCancer, Lung
Conjupro Biotherapeutics, Inc. 132
Testing effectiveness (Phase 2)Active Not RecruitingNCT03573700
What this trial is testing

Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia, Refractory
St. Jude Children's Research Hospital 24
Not applicableStudy completedNCT05440409
What this trial is testing

CAR-Multicenter Analysis (CAR-MA): Retrospective Study to Characterize CAR T-cell Outcomes and Related Toxicities in Children and Young Adults With B-ALL

Who this might be right for
Leukemia, Acute LymphoblasticLymphoblastic Leukemia, Acute, Childhood
National Cancer Institute (NCI) 57
Very early researchStudy completedNCT02117115
What this trial is testing

Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic+1 more
Washington University School of Medicine 21
Not applicableStudy completedNCT01314079
What this trial is testing

Follow-up Study of Autologous Cultured Adipose-derived Stem Cells for the Crohn's Fistula

Who this might be right for
Crohn's DiseaseFistula
Anterogen Co., Ltd. 37
Testing effectiveness (Phase 2)Looking for participantsNCT07572396
What this trial is testing

Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

Who this might be right for
High-risk HPV (Any Strain)LSIL, Low Grade Squamous Intraepithelial LesionASC-US+3 more
Amplexd Therapeutics, Inc. 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT04233346
What this trial is testing

The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation

Who this might be right for
Chronic Myeloid LeukemiaAcute Lymphoblastic Leukemia
Otsuka Beijing Research Institute 93
Early research (Phase 1)Study completedNCT02712346
What this trial is testing

The Role of Endothelin-1 in Sickle Cell Disease

Who this might be right for
Sickle Cell Anemia
Augusta University 26
Testing effectiveness (Phase 2)Ended earlyNCT00540995
What this trial is testing

Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+12 more
City of Hope Medical Center 25
Testing effectiveness (Phase 2)UnknownNCT01958177
What this trial is testing

Clinical Study to Evaluate the Safety and Efficacy BMMNC in Cerebellar Ataxia

Who this might be right for
Cerebellar Ataxia
Chaitanya Hospital, Pune 20
Testing effectiveness (Phase 2)WithdrawnNCT02371577
What this trial is testing

Evaluation of the Immune Restoration Potential Of Lenalidomide

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
University of California, San Diego
Testing effectiveness (Phase 2)Study completedNCT00241631
What this trial is testing

Enhancement of in-Vitro GC Function in Patients With COPD

Who this might be right for
COPD
Imperial College London 49
Early research (Phase 1)Study completedNCT03263637
What this trial is testing

Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies

Who this might be right for
Relapsed or Refractory Haematological Malignancies IncludingAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+8 more
AstraZeneca 44
Not applicableEnded earlyNCT05247957
What this trial is testing

NKG2D CAR-NK Cell Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Safety and Efficacy
Hangzhou Cheetah Cell Therapeutics Co., Ltd 9
Next Page